CS Paper Radar

RangeFinder: Predicting Ligand Property Ranges from Protein Pockets

Alan Nadelsticher Ruvalcaba, Chris Alvin, Supratik Mukhopadhyay, Adam Bess

cs.LG q-bio.BM ·submitted 2026-11-02 16:21 UTC · v1
publishedcode/data

Abstract

Identifying ligands for a protein target requires searching a vast chemical space for a comparatively small set of compatible molecules. Existing machine learning approaches primarily address this problem by generating candidate ligands or scoring individual protein-ligand pairs, but provide limited information about the broader chemical space compatible with a binding pocket. We introduce RangeFinder, an SE(3)-equivariant transformer pocket-level model, trained and evaluated on BioLiP2 data, that predicts ranges over nine physicochemical ligand properties directly from pocket structure, chemistry, and evolutionary context. Using an intersection-over-union objective and evaluation metric (range-IoU), RangeFinder achieves a range-IoU of $0.464 \pm 0.002$, outperforming all deployable baselines while requiring only $12.2$ ms per pocket. We also quantify our method's ability to reduce the ligand search space while retaining compatible binders; in this regard, RangeFinder achieves a Reduction-Recall F-Score of $0.543 \pm 0.011$ --- once again outperforming all deployable baselines. Ablation experiments indicate that RangeFinder's performance depends more strongly on the density and quality of ligand supervision than on any individual input modality or specialized training strategy. Together, these results position RangeFinder as an inexpensive and effective molecular filtering prior, with demonstrated potential in narrowing the ligand search space of target pockets before docking, generation, or synthesis. The code for this project can be found at: https://github.com/alannadels/RangeFinder.

Comment
Accepted at the AI for Drug Discovery workshop --- NeurIPS 2026

Closest papers

Nearest neighbours by meaning across the whole index.

zPocket: Better Pocket Finding with Frozen Co-Folding Features

cs.LG cs.AI ·2026-10-13 ·Tally Portnoi, Allison M Keys, Benjamin R DiFrancesco, Nate Gruver
benchmark similarity 0.70
Abstract

Identifying protein-ligand binding sites (pockets) is important for understanding protein function and developing drugs. However, no public method has leveraged co-folding models for novel pocket prediction; furthermore, this task lacks a suitable benchmark as existing benchmarks are within the training distribution of co-folding models. We therefore developed PocketWatch,a curated dataset of biologically relevant ligand pockets. The PocketWatch test set consists of unseen pockets stratified by sequence similarity, structural similarity, and crypticity to enable evaluation of generalization to novel and challenging pockets. Using this dataset, we develop zPocket, a method that trains pocket-prediction heads on top of frozen features from co-folding models. We show that zPocket heads outperform baseline methods across all stratifications. Our best zPocket model achieves overall per-target AUPRC of 0.745 compared to 0.598 and 0.595 for the strongest baselines, VN-EGNN and UniSite-1D retrained on the PocketWatch split (0.559 and 0.531 when using the published weights); the widely used P2Rank reaches 0.477. We further show that zPocket can be used to outperform baseline methods on top-N+2 recall of predicted pocket centroids through clustering per-residue predictions or using zPocket to rescore centroids proposed by other models. Finally, we explore two applications of zPocket: crystallographic fragment screens and a proteome-scale scan for uncharacterized pockets on human proteins. Together these results suggest that zPocket heads built on co-folding trunk features can greatly advance ligand binding site prediction.

0.33

Molecular Prior Networks

cs.LG cs.AIcs.CE ·2026-11-03 ·Pawel Gomoluch, Anthony Bradley
publishedbenchmark similarity 0.66
Abstract · Accepted to the NeurIPS 2026 Workshop on AI for Drug Discovery: Bridging the Translation Gap

Predicting affinity between small molecules and their protein targets remains one of the central problems in drug discovery. Due to the substantial cost of wet-lab experiments, machine learning models of drug-target affinity are usually trained on relatively small datasets, ranging from tens to hundreds of molecules. Given the inherent difficulty of generalization between different targets and chemical series, existing datasets of protein-ligand affinities are typically not used for new projects. At the same time, tabular foundation models, including Prior-data Fitted Networks, have recently shown how transformers can be used to solve machine learning problems in a single forward pass of the network, after being trained over a large corpus of, typically, synthetic datasets. Inspired by that line of work, we propose a novel affinity modelling approach, in which the labels of the query molecules are predicted from the labelled support molecules in a single forward pass of a transformer model. The model is trained on thousands of existing affinity datasets, enabling it to capture the general patterns of molecular activity across different targets, chemical series and dataset sizes. For the smallest support sets, our model matches the state of the art on the regression variant of the FS-Mol benchmark, while being faster than existing methods, thanks to the lack of task-specific training. A comparison against a reduced variant of our architecture, which amounts to kernel regression in a meta-learned feature space, shows that the predictive performance of the transformer model is only partially explained by simple molecular similarity.

0.25

ProbeMatchDTI: Probe-Driven Multi-Scale Biochemical Pattern Matching for Drug-Target Interaction Prediction

cs.LG cs.AI ·2026-09-02 ·Quan Hao, Mengyue Fan, Zifan Dong, Youru Li, Jianduo Zhao +6 more
code/data similarity 0.65
Abstract

Drug-target interaction (DTI) prediction is an important task in AI-driven drug discovery. Although recent biochemical representation learning methods have improved DTI prediction, their passive feature aggregation tends to favor dominant molecular patterns while suppressing weak yet binding-relevant signals, such as functional groups and residue-context patterns, limiting the modeling of multi-scale biochemical correspondences. To address this issue, we propose ProbeMatchDTI, a pattern-probe-driven framework comprising IterProbe and BindingProbe. IterProbe explicitly retains contextual states across refinement depths and uses learnable probes to select them at each position before cross-entity matching, thereby preserving weak biochemical patterns and strengthening associations among functional groups, local motifs, and molecular scaffolds. BindingProbe then characterizes cross-entity drug-protein complementarity at local biochemical-unit and whole-pair levels, jointly modeling fine-grained interactions and multi-scale correspondences while preserving weaker binding-relevant associations. Extensive experiments demonstrate the superiority of ProbeMatchDTI, achieving 2.0% and 0.5% higher AUC-ROC on BindingDB and DrugBank, respectively. Feature-level pattern analyses further characterize its probe-driven behavior in cross-scale biochemical pattern matching. We further connect ProbeMatchDTI predictions with an evidence-guided downstream drug-discovery workflow, demonstrating their utility for candidate refinement and validation planning. Our code is available at https://github.com/developer-hq/ProbeMatchDTI

0.28

Auditable Algebraic Counting Field for Cryptic-Pocket Detection from Apo Structures

cs.LG q-bio.BM ·2026-10-01 ·Shan Yu, Xuening Wu
published similarity 0.65
Abstract · Accepted for publication in Pacific Symposium on Biocomputing (PSB) 2027

Cryptic ligand-binding pockets are not apparent in experimentally determined apo structures, making them difficult to identify from unbound receptor geometry. A complementary challenge is to make the structural measurements and learned evidence behind each prediction directly inspectable. We introduce a supervised algebraic counting field (ACF) for predicting cryptic-pocket residues from apo structures. ACF compiles explicit geometric, physicochemical, and topological features into compact, integer-weighted lookup tables. Each prediction score can be reconstructed from feature values, training counts, table weights, and spatial aggregation, without sequence search, structural-template transfer, or a protein language model at inference. We evaluate ACF on CryptoBench and two locked external collections, separating ranking performance from the effects of residue-calling budgets. On an external set of 57 post-CryptoBench apo-holo units, ACF exceeded P2Rank by +0.044 in mean paired ROC-AUC (multiplicity-adjusted 95% CI [+0.010, +0.079]). The advantage was dataset-dependent: official-fold ROC-AUC and matched-budget F1 differences against P2Rank remained unresolved, and a second external evaluation did not confirm gains from added structural features. ACF thus provides a compact predictor with externally validated signal and an inspectable path from structural measurements and training counts to residue scores.

0.37

Pyrite: Building and Benchmarking Protein-Ligand Pose Ranking Agents

cs.LG q-bio.QM ·2026-11-10 ·Megha Srivastava, Michael H. Lim, Allison M. Keys, Pranav Murugan, Nate Gruver
publishedbenchmark similarity 0.64
Abstract · 32 pages, Agentic AI for Biological Discovery Workshop (NeurIPS 2026)

Predicting how a ligand binds to its target is central to small-molecule drug discovery. Modern cofolding models can generate diverse candidate poses, but reliably ranking these candidates remains challenging. We introduce Pyrite, a pairwise pose-ranking benchmark comprising 1,500 pose pairs across diverse protein-ligand complexes. Expert chemists equipped with 3D visualization tools and physics-based scores perform near chance, highlighting the difficulty of interpreting available chemical signals. To investigate automated ranking, we introduce PyriteRep, a structured representation of molecular geometry, protein-ligand interactions, and physicochemical scores, and develop two LLM-based agents: PyriteReasoner, which directly compares poses through text-based reasoning, and PyriteFeaturizer, which generates executable code to construct features for logistic regression, optionally incorporating features derived from LLM subcalls. These agents achieve up to 67% and 74% accuracy, respectively, exceeding observed expert performance. LLM-guided feature discovery generally outperforms direct reasoning, while Group Relative Policy Optimization (GRPO) improves open-weight models, enabling them to match or surpass closed-source frontier models in our evaluations. These results establish Pyrite as a challenging test of pose-ranking ability and highlight LLM-guided feature discovery as a promising approach to interpret and combine the outputs of computational chemistry tools.

0.41

ProteoCraft: Protein Design as Proposal-Verification Search

cs.CE cs.AIq-bio.BM ·2026-11-02 ·Fang Wu, Hongbin Lin, Bingchen Duan, Yuchen Wang, Li Erran Li +22 more
code/data similarity 0.64
Abstract

Protein-protein interactions underpin nearly all biological processes. Yet, designing proteins with desired interactions remains challenging due to the structural complexity governing molecular recognition. This study views protein design as a search optimization problem over a combinatorial sequence space under expensive structural evaluation. Toward this goal, we introduce a novel tree-based search framework, ProteoCraft, that employs approximate structural gradients from diffusion-based structure predictors as effective proposal policies to specify where the search should explore. Complete no-gradient inference of folding models separately assigns values to the resulting sequences, determining what is good. ProteoCraft allocates this verification budget through a coarse-to-fine paradigm: multi-site edits first explore distinct sequence basins, then verified promising states undergo strict single-site refinement. Across fourteen de novo binder-design settings spanning eight target proteins, five immune-relevant TCR-facing targets, and four localized CDR redesign tasks, ProteoCraft improves design quality and high-confidence yield. These improvements persist under independent AF2-IG and Rosetta-based interface evaluation. Prospective experimental validation further yielded an 82.9% binding hit rate for PD-L1 miniproteins, with a best measured KD of 0.879 nM, and confirmed binding of designed IFNAR2 VHH. Our code is available at https://github.com/smiles724/ProteoCraft_v1.

0.28

PETA:Parameter-Efficient Test-Time Adaptation for Virtual Screening

cs.LG ·2026-08-20 ·Jia-Qi Lin, Yinghua Yao, Chang-Dong Wang, Yew-Soon Ong, Yuangang Pan
similarity 0.64
Abstract

Accurately ranking active ligands for a target protein pocket from massive chemical libraries remains a central challenge in virtual screening. DrugCLIP and its recent extensions substantially accelerate this process by encoding protein pockets and molecules into a shared embedding space. Despite this progress, further performance improvements typically require retraining the entire model, incurring substantial computational overhead and making target-specific customization inefficient. In this work, we formulate the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and propose PETA, a parameter-efficient framework that directly adapts pretrained model at test time. Given a target pocket, PETA constructs pocket-specific negatives through molecular diffusion and chemical validity filtering, and further moves them toward the reference ligand retrieved from structural databases via embedding-space mixup to create more challenging ranking tasks. A ranking objective then places greater emphasis on suppressing high-scoring invalid candidates that could contaminate the top-ranked screening results, providing structured supervision for lightweight adaptation. Experiments across diverse benchmarks demonstrate that this lightweight, pocket-specific adaptation outperforms both pretrained and fully retrained baselines while updating only the LayerNorm parameters, which account for approximately $0.03\%$ of the full model.

0.16

Beyond Random Splits: Evaluating Drug-Target Affinity Models Under Chemically and Biologically Motivated Distribution Shifts Copy

cs.LG ·2026-10-02 ·Minjae Chung, Clara Li, Malar Paavai Muthukumaran, Shaunna Wang, Aniket Ramkrishnan Iyer +6 more
published similarity 0.64
Abstract · Accepted to the NeurIPS 2026 Workshop on AI for Drug Discovery (AI4DD)

Drug-target affinity (DTA) prediction is widely used to prioritize candidate compounds before costly experimental screening. DTA models are often compared under a single data split, even though deployment may require extrapolation to new chemical series, new protein targets, or both. We ask whether the distribution shift used for evaluation changes which architecture appears best. We curate 718,800 unique drug-protein pairs from the ChEMBL and BindingDB datasets. We compare a Morgan-fingerprint + protein-CNN baseline with 12 controlled architectures that combine four drug representations with three ESM-2 interaction modes. Mean validation RMSE increases from 0.950 and 0.945 under scaffold and fingerprint-cluster OOD to 1.299 and 1.321 under protein-cluster and dual OOD. Model rankings are similar across the two chemical shifts (tau = 0.79), but agreement with scaffold OOD falls under protein OOD (tau = 0.39) and reverses under dual OOD (tau = -0.55). Held-out evaluation, repeated seeds, group-aware bootstrap analysis, and a size-matched control support the same conclusion: architecture selection depends on the form of extrapolation, not only on average error or training-set size. DTA benchmarks should therefore match the chemical and target shifts expected at deployment.

0.24